Table 5. Outcomes of treatment.

Variable	Marfan syndrome	No Marfan syndrome	P value
Type A
Death
Medical	5 (33.3%)	219 (55.4%)	0.091
Surgical	19 (13.1%)	575 (16.6%)	0.265
Endovascular	1 (50.0%)	28 (38.9%)	1.000
Hybrid	0 (0.0%)	8 (13.8%)	1.000
Neurological complications
Medical	0 (0.0%)	3 (7.7%)	1.000
Surgical	10 (8.2%)	311 (10.5%)	0.420
Endovascular	0 (0.0%)	12 (20%)	1.000
Hybrid	0 (0.0%)	7 (13.2%)	1.000
Type B
Death
Medical	2 (4.3%)	106 (7.8%)	0.576
Surgical	0 (0.0%)	37 (17.6%)	0.011
Endovascular	1 (5.6%)	61 (11.1%)	0.708
Hybrid	0 (0.0%)	7 (14.3%)	1.000
Neurological complications
Medical	0 (0.0%)	0 (0.0%)	N/A
Surgical	2 (7.7%)	24 (13.3%)	0.542
Endovascular	0 (0.0%)	51 (10.3%)	0.380
Hybrid	0 (0.0%)	4 (10.0%)	1.000